TrivarX Limited
MDBIF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $1,129 | $889 | $960 | $1,005 |
| % Growth | 27% | -7.5% | -4.5% | – |
| Cost of Goods Sold | $0 | $93 | $1,176 | $1 |
| Gross Profit | $1,129 | -$93 | -$1,154 | $1,004 |
| % Margin | 100% | -10.5% | -120.2% | 99.9% |
| R&D Expenses | $26 | $14 | $307 | $803 |
| G&A Expenses | $0 | $0 | $701 | $1,409 |
| SG&A Expenses | $974 | $2,010 | $779 | $1,430 |
| Sales & Mktg Exp. | $0 | $0 | $78 | $20 |
| Other Operating Expenses | $0 | $0 | $437 | -$724 |
| Operating Expenses | $1,001 | $2,024 | $1,523 | $1,509 |
| Operating Income | $128 | -$2,117 | $18 | -$504 |
| % Margin | 11.4% | -238.2% | 1.9% | -50.1% |
| Other Income/Exp. Net | -$1,071 | $880 | -$3,089 | -$12,212 |
| Pre-Tax Income | -$943 | -$1,237 | -$3,071 | -$12,716 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$943 | -$1,237 | -$3,071 | -$12,716 |
| % Margin | -83.5% | -139.2% | -319.7% | -1,264.7% |
| EPS | -0.002 | -0.004 | -0.017 | -0.12 |
| % Growth | 52.5% | 76.9% | 85.6% | – |
| EPS Diluted | -0.002 | -0.004 | -0.017 | -0.12 |
| Weighted Avg Shares Out | 496,437 | 309,273 | 177,589 | 102,510 |
| Weighted Avg Shares Out Dil | 496,437 | 309,273 | 177,589 | 102,510 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $34 | $13 | $13 | $9 |
| Depreciation & Amortization | $52 | $93 | $541 | $88 |
| EBITDA | -$857 | -$1,333 | -$2,520 | -$2,584 |
| % Margin | -75.9% | -149.9% | -262.3% | -257% |